Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FUtile Reperfusion in acuTe iscHEmic stRoke- FURTHER

NCT07045987 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07045987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07045987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FUtile Reperfusion in acuTe iscHEmic stRoke- FURTHER
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2025
Completion date
May 31, 2029
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke (ais), endovascular thrombectomy, neurovascular unit- brain lymphatic system